Clinical Trial Update: Safety and Immunogenicity of Recombinant Hepatitis B Vaccine Sci-B-Vac® Compared to Engerix-B® [Phase 3]

View source ↗

Summary

Phase 3 trial comparing Sci-B-Vac to Engerix-B for safety and immunogenicity in Hepatitis B was completed with results posted in 2022.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• Engerix-B (hepatitis B vaccine)
• Sci-B-Vac (hepatitis B vaccine (recombinant))

Snippet

Sponsor: VBI Vaccines Inc. | Conditions: Hepatitis B | Phase 3 | Status: COMPLETED | Results posted: 2022-07-25